• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在无菌仔猪中,通过减毒人轮状病毒进行口服初免,随后用含有免疫刺激复合物的2/6-轮状病毒样颗粒进行口服加强免疫后的保护作用和抗体反应。

Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs.

作者信息

Nguyen T V, Iosef C, Jeong K, Kim Y, Chang K-O, Lovgren-Bengtsson K, Morein B, Azevedo M S P, Lewis P, Nielsen P, Yuan L, Saif L J

机构信息

Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, The Ohio State University, 1680 Madison Avenue, Wooster, OH 44691-4096, USA.

出版信息

Vaccine. 2003 Sep 8;21(25-26):4059-70. doi: 10.1016/s0264-410x(03)00267-6.

DOI:10.1016/s0264-410x(03)00267-6
PMID:12922143
Abstract

We evaluated antibody responses and protection induced by attenuated Wa human rotavirus (AttHRV) and VP2/6-rotavirus-like particles (VLP), 100 or 250 microg/dose, with immunostimulating complexes (ISCOM) (VLP/ISCOM) each given orally, alone or sequentially to gnotobiotic pigs. The AttHRV-VLP 250 microg/ISCOM and three-dose-AttHRV (AttHRV3x) groups had significantly higher serum IgA, IgG and intestinal IgA antibody titers to HRV pre-challenge than the three-dose-VLP 100 microg/ISCOM group (VLP/ISCOM3x) and controls (diluent/ISCOMmatrix). Protection rates against viral shedding and diarrhea were highest in the AttHRV-VLP250 microg/ISCOM and AttHRV3x groups, lower in the AttHRV-VLP 100 microg/ISCOM group, with no protection in the VLP/ISCOM3x group and controls. Thus, VLP/ISCOM boosted antibody titers and protection after priming with AttHRV.

摘要

我们评估了减毒Wa人轮状病毒(AttHRV)和VP2/6-轮状病毒样颗粒(VLP)(剂量分别为100或250微克)与免疫刺激复合物(ISCOM)(VLP/ISCOM)单独或先后经口给予无菌猪后诱导的抗体反应和保护作用。与三剂量100微克/ISCOM的VLP组(VLP/ISCOM3x)和对照组(稀释剂/ISCOM基质)相比,250微克/ISCOM的AttHRV-VLP组和三剂量AttHRV组(AttHRV3x)在攻击前对HRV的血清IgA、IgG和肠道IgA抗体滴度显著更高。AttHRV-VLP 250微克/ISCOM组和AttHRV3x组对病毒排泄和腹泻的保护率最高,AttHRV-VLP 100微克/ISCOM组较低,VLP/ISCOM3x组和对照组无保护作用。因此,VLP/ISCOM在用AttHRV进行初免后可提高抗体滴度和保护作用。

相似文献

1
Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs.在无菌仔猪中,通过减毒人轮状病毒进行口服初免,随后用含有免疫刺激复合物的2/6-轮状病毒样颗粒进行口服加强免疫后的保护作用和抗体反应。
Vaccine. 2003 Sep 8;21(25-26):4059-70. doi: 10.1016/s0264-410x(03)00267-6.
2
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.采用口服减毒人轮状病毒(HRV)进行初次免疫,并用含免疫刺激复合物(ISCOM)的鼻内VP2/6轮状病毒样颗粒(VLP)进行加强免疫的新的初免/加强疫苗策略后,无菌猪对人轮状病毒(HRV)的抗体反应。
Clin Exp Immunol. 2004 Mar;135(3):361-72. doi: 10.1111/j.1365-2249.2004.02395.x.
3
High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen.高滴度的循环母体抗体可抑制由减毒轮状病毒初免和轮状病毒样颗粒免疫刺激复合物加强疫苗方案诱导的效应B细胞和记忆B细胞反应。
Clin Vaccine Immunol. 2006 Apr;13(4):475-85. doi: 10.1128/CVI.13.4.475-485.2006.
4
Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.无菌猪中连续使用复制型和非复制型轮状病毒疫苗诱导的血清和肠道抗体反应强度及其与保护作用的相关性
Clin Diagn Lab Immunol. 2004 Jan;11(1):12-20. doi: 10.1128/cdli.11.1.12-20.2004.
5
Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.在无菌猪模型中,初免/加强轮状病毒DNA疫苗诱导的黏膜和全身抗体反应及保护作用。
Vaccine. 2005 Jun 10;23(30):3925-36. doi: 10.1016/j.vaccine.2005.03.009. Epub 2005 Apr 9.
6
An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model.在新生无菌仔猪模型中,使用减毒人轮状病毒或VP2和VP6病毒样颗粒与免疫刺激复合物的口服与鼻内初免/加强免疫方案会影响对轮状病毒的保护作用和抗体分泌细胞反应。
Clin Vaccine Immunol. 2010 Mar;17(3):420-8. doi: 10.1128/CVI.00395-09. Epub 2010 Jan 27.
7
Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.在无菌仔猪中,联合口服减毒的Wa人轮状病毒和鼻内接种含突变大肠杆菌不耐热毒素的Wa 2/6-VLPs所引发的保护性免疫和抗体分泌细胞反应。
J Virol. 2001 Oct;75(19):9229-38. doi: 10.1128/JVI.75.19.9229-9238.2001.
8
Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes.用减毒的Wa人轮状病毒和与免疫刺激复合物相关的Wa 2/6轮状病毒样颗粒经口免疫悉生猪后的全身和肠道抗体分泌细胞反应及保护作用
Vaccine. 2002 Mar 15;20(13-14):1741-53. doi: 10.1016/s0264-410x(02)00031-2.
9
Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.在人类轮状病毒疾病的悉生猪模型中,针对沃(Wa)株人类轮状病毒NSP4肠毒素的全身和肠道抗体反应。
J Med Virol. 2002 Sep;68(1):119-28. doi: 10.1002/jmv.10178.
10
Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.乳杆菌和双歧杆菌增强黏膜 B 细胞反应,并在新生无菌猪疾病模型中差异调节对口服人轮状病毒疫苗的全身抗体反应。
Gut Microbes. 2014;5(5):639-51. doi: 10.4161/19490976.2014.969972.

引用本文的文献

1
Development of a human rotavirus induced diarrhea model in Chinese mini-pigs.中国小型猪人轮状病毒诱导腹泻模型的建立
World J Gastroenterol. 2016 Aug 21;22(31):7135-45. doi: 10.3748/wjg.v22.i31.7135.
2
Detection and genetic diversity of porcine group A rotaviruses in historic (2004) and recent (2011 and 2012) swine fecal samples in Ohio: predominance of the G9P[13] genotype in nursing piglets.俄亥俄州历史(2004 年)和近期(2011 年和 2012 年)猪粪便样本中猪群 A 轮状病毒的检测和遗传多样性:在哺乳仔猪中 G9P[13]基因型占主导地位。
J Clin Microbiol. 2013 Apr;51(4):1142-51. doi: 10.1128/JCM.03193-12. Epub 2013 Jan 30.
3
Detection and characterization of group C rotaviruses in asymptomatic piglets in Ireland.
爱尔兰无症状仔猪中C组轮状病毒的检测与特征分析
J Clin Microbiol. 2008 Sep;46(9):2973-9. doi: 10.1128/JCM.00809-08. Epub 2008 Jul 16.
4
A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.一种佐剂为免疫刺激复合物(ISCOM)或黏膜淋巴组织趋化因子(mLT)的人诺如病毒样颗粒疫苗,在悉生猪疾病模型中可诱导细胞因子和抗体反应,并对同源GII.4型人诺如病毒产生保护作用。
Vaccine. 2007 Dec 5;25(50):8448-59. doi: 10.1016/j.vaccine.2007.09.040. Epub 2007 Oct 5.
5
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.采用口服减毒人轮状病毒(HRV)进行初次免疫,并用含免疫刺激复合物(ISCOM)的鼻内VP2/6轮状病毒样颗粒(VLP)进行加强免疫的新的初免/加强疫苗策略后,无菌猪对人轮状病毒(HRV)的抗体反应。
Clin Exp Immunol. 2004 Mar;135(3):361-72. doi: 10.1111/j.1365-2249.2004.02395.x.